Cargando…

Elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes

BACKGROUND: Although albuminuria has been linked to heart failure in the general population, the relationship between urine albumin-to-creatinine ratio (uACR) and heart failure in type 2 diabetes patients is not well understood. We aimed to investigate the relationship between uACR and new-onset hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Jie, Sang, Dasen, Zhen, Libo, Zhang, Xinxin, Li, Yuejun, Wang, Guodong, Chen, Shuohua, Wu, Shouling, Zhang, Wenjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040119/
https://www.ncbi.nlm.nih.gov/pubmed/36966320
http://dx.doi.org/10.1186/s12933-023-01796-6
_version_ 1784912411972599808
author Tao, Jie
Sang, Dasen
Zhen, Libo
Zhang, Xinxin
Li, Yuejun
Wang, Guodong
Chen, Shuohua
Wu, Shouling
Zhang, Wenjuan
author_facet Tao, Jie
Sang, Dasen
Zhen, Libo
Zhang, Xinxin
Li, Yuejun
Wang, Guodong
Chen, Shuohua
Wu, Shouling
Zhang, Wenjuan
author_sort Tao, Jie
collection PubMed
description BACKGROUND: Although albuminuria has been linked to heart failure in the general population, the relationship between urine albumin-to-creatinine ratio (uACR) and heart failure in type 2 diabetes patients is not well understood. We aimed to investigate the relationship between uACR and new-onset heart failure (HF) in type 2 diabetics. METHODS: We included 9287 Chinese participants with type 2 diabetes (T2D) but no heart failure (HF) who were assessed with uACR between 2014 and 2016. The participants were divided into three groups based on their baseline uACR: normal (< 3 mg/mmol), microalbuminuria (3–30 mg/mmol), and macroalbuminuria (≥ 30 mg/mmol). The relationship between uACR and new-onset HF was studied using Cox proportional hazard models and restricted cubic spline. The area under the receiver operating characteristic curve (AUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were used to see if incorporating uACR into existing models could improve performance. RESULTS: 216 new-onset HF cases (2.33%) were recorded after a median follow-up of 4.05 years. When compared to normal uACR, elevated uACR was associated with a progressively increased risk of new-onset HF, ranging from microalbuminuria (adjusted HR, 2.21; 95% CI 1.59–3.06) to macroalbuminuria (adjusted HR, 6.02; 95% CI 4.11–8.80), and 1 standard deviation (SD) in ln (uACR) (adjusted HR, 1.89; 95% CI 1.68–2.13). The results were consistent across sex, estimated glomerular filtration rate, systolic blood pressure, and glycosylated hemoglobin subgroups. The addition of uACR to established HF risk models improved the HF risk prediction efficacy. CONCLUSIONS: Increasing uACR, even below the normal range, is an independent risk factor for new-onset HF in a type 2 diabetic population. Furthermore, uACR may improve HF risk prediction in community-based T2D patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-023-01796-6.
format Online
Article
Text
id pubmed-10040119
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100401192023-03-27 Elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes Tao, Jie Sang, Dasen Zhen, Libo Zhang, Xinxin Li, Yuejun Wang, Guodong Chen, Shuohua Wu, Shouling Zhang, Wenjuan Cardiovasc Diabetol Research BACKGROUND: Although albuminuria has been linked to heart failure in the general population, the relationship between urine albumin-to-creatinine ratio (uACR) and heart failure in type 2 diabetes patients is not well understood. We aimed to investigate the relationship between uACR and new-onset heart failure (HF) in type 2 diabetics. METHODS: We included 9287 Chinese participants with type 2 diabetes (T2D) but no heart failure (HF) who were assessed with uACR between 2014 and 2016. The participants were divided into three groups based on their baseline uACR: normal (< 3 mg/mmol), microalbuminuria (3–30 mg/mmol), and macroalbuminuria (≥ 30 mg/mmol). The relationship between uACR and new-onset HF was studied using Cox proportional hazard models and restricted cubic spline. The area under the receiver operating characteristic curve (AUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were used to see if incorporating uACR into existing models could improve performance. RESULTS: 216 new-onset HF cases (2.33%) were recorded after a median follow-up of 4.05 years. When compared to normal uACR, elevated uACR was associated with a progressively increased risk of new-onset HF, ranging from microalbuminuria (adjusted HR, 2.21; 95% CI 1.59–3.06) to macroalbuminuria (adjusted HR, 6.02; 95% CI 4.11–8.80), and 1 standard deviation (SD) in ln (uACR) (adjusted HR, 1.89; 95% CI 1.68–2.13). The results were consistent across sex, estimated glomerular filtration rate, systolic blood pressure, and glycosylated hemoglobin subgroups. The addition of uACR to established HF risk models improved the HF risk prediction efficacy. CONCLUSIONS: Increasing uACR, even below the normal range, is an independent risk factor for new-onset HF in a type 2 diabetic population. Furthermore, uACR may improve HF risk prediction in community-based T2D patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-023-01796-6. BioMed Central 2023-03-25 /pmc/articles/PMC10040119/ /pubmed/36966320 http://dx.doi.org/10.1186/s12933-023-01796-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tao, Jie
Sang, Dasen
Zhen, Libo
Zhang, Xinxin
Li, Yuejun
Wang, Guodong
Chen, Shuohua
Wu, Shouling
Zhang, Wenjuan
Elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes
title Elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes
title_full Elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes
title_fullStr Elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes
title_full_unstemmed Elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes
title_short Elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes
title_sort elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040119/
https://www.ncbi.nlm.nih.gov/pubmed/36966320
http://dx.doi.org/10.1186/s12933-023-01796-6
work_keys_str_mv AT taojie elevatedurinealbumintocreatinineratioincreasestheriskofnewonsetheartfailureinpatientswithtype2diabetes
AT sangdasen elevatedurinealbumintocreatinineratioincreasestheriskofnewonsetheartfailureinpatientswithtype2diabetes
AT zhenlibo elevatedurinealbumintocreatinineratioincreasestheriskofnewonsetheartfailureinpatientswithtype2diabetes
AT zhangxinxin elevatedurinealbumintocreatinineratioincreasestheriskofnewonsetheartfailureinpatientswithtype2diabetes
AT liyuejun elevatedurinealbumintocreatinineratioincreasestheriskofnewonsetheartfailureinpatientswithtype2diabetes
AT wangguodong elevatedurinealbumintocreatinineratioincreasestheriskofnewonsetheartfailureinpatientswithtype2diabetes
AT chenshuohua elevatedurinealbumintocreatinineratioincreasestheriskofnewonsetheartfailureinpatientswithtype2diabetes
AT wushouling elevatedurinealbumintocreatinineratioincreasestheriskofnewonsetheartfailureinpatientswithtype2diabetes
AT zhangwenjuan elevatedurinealbumintocreatinineratioincreasestheriskofnewonsetheartfailureinpatientswithtype2diabetes